Vermillion, Inc. (VRML)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
1.37-0.05 (-3.52%)
At close: 4:00 PM EDT
People also watch:
ROSGAPPYPSDVTTHIPIP
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open1.40
Prev Close1.42
Bid1.05 x 2000
Ask0.00 x
Day's Range1.37 - 1.41
52wk Range0.92 - 2.29
1y Target EstN/A
Market Cap71.54M
P/E Ratio (ttm)-3.73
Beta0.76
Volume21,817
Avg Vol (3m)44,976
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Capital Cube15 days ago

    ETF’s with exposure to Vermillion, Inc. : August 16, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to Vermillion, Inc. Here are 5 ETF’s with the largest exposure to VRML-US. Comparing the performance and risk of Vermillion, Inc. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)

  • Vermillion, Inc. :VRML-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016
    Capital Cube19 days ago

    Vermillion, Inc. :VRML-US: Earnings Analysis: Q2, 2016 By the Numbers : August 12, 2016

    Categories: Yahoo Finance Click here to see latest analysis Vermillion, Inc. reports financial results for the quarter ended June 30, 2016. We analyze the earnings along side the following peers of Vermillion, Inc. – Cepheid, Biocept, Inc., Foundation Medicine, Inc., Quest Diagnostics Incorporated, Quidel Corporation and Myriad Genetics, Inc. (CPHD-US, BIOC-US, FMI-US, DGX-US, QDEL-US and MYGN-US) that have ... Read more (Read more...)

  • Associated Press21 days ago

    Vermillion reports 2Q loss

    On a per-share basis, the Austin, Texas-based company said it had a loss of 7 cents. The diagnostic and bio-analytical company posted revenue of $709,000 in the period. The company's shares closed at $1.34. ...